Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2026-01-18 @ 10:08 AM
Study NCT ID:
NCT02613403
Status:
TERMINATED
Last Update Posted:
2024-05-22
First Post:
2015-11-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-10
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-27
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-20
First Submit QC Date:
None
Study First Post Date:
2015-11-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-02-02
Results First Submit QC Date:
None
Results First Post Date:
2018-03-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-20
Last Update Post Date:
2024-05-22
Last Update Post Date Type:
ACTUAL